Logo Image
|Articles|April 4, 2016

Building Regulatory Capacity: MRCT Workshop in Singapore

Author(s)DIA

With the globalization of the pharmaceutical industry, multiregional clinical trials (MRCTs) have steadily increased over the past decade. In March 2016, the Centre of Regulatory Excellence (CoRE), Duke-NUS Medical School Singapore – recently designated as an APEC Center of Excellence (CoE) for regulatory training in MRCTs – organized and hosted the second APEC CoE MRCT Workshop in Singapore, following the successful pilot Workshop in Singapore in 2014.

Read more here.

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: Nxera Licenses EP4 Agonist to AbbVie
How microgravity is opening new possibilities for drug R&D and manufacturing, a pharma funding roundup covers Boehringer Ingelheim’s up-to-$7 billion oncology licensing deal with Sino Biopharmaceutical and Nxera Pharma’s EP4 agonist deal with AbbVie, and CytoDyn’s Dr. Jay Lalezari on why Leronlimab isn’t just another repurposed drug.
Read more
The Promise of Microgravity for R&D and Manufacturing
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.
Read more